Skip to main content

3M guidance

  • MMM · NYSE
  • Medical devices
  • Industrial Conglomerates
  • S&P 500
$182.47+0.43%Close 17 Nov 2026 · Market value $93.73B

In its results release of 20 Oct 2026 (Q3 FY2026), 3M gave 1 forecast in figures, among them EPS (adjusted) of $9.10 to $9.15 for FY2026.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 20 Oct 2026

MeasurePeriodGuidanceAs stated
EPS · Adjusted · RaisedFY2026$9.10 to $9.152026 adjusted EPS guidance raised to $9.10 to $9.15, incorporating new basis 1

Source: the company's earnings release.

Guidance against results last two years

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
EPS · AdjustedFY2026$9.10 to $9.15Raised twice—To come
Operating cash flow · AdjustedFY2026$5.80B to $6.00BRaised once—To come
Revenue growthFY2025+0.5% to +1.5%Given once+1.52%Within the range
Revenue growthFY2024+1%Given once−0.14%Below the range

MMM in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.